Low-Field Bedside Brain Magnetic Resonance Imaging in Pediatric Extracorporeal Membrane Oxygenation

Sponsor
Children's Mercy Hospital Kansas City (Other)
Overall Status
Recruiting
CT.gov ID
NCT06074406
Collaborator
(none)
10
1
1
24
0.4

Study Details

Study Description

Brief Summary

The primary object of the study is to further characterize safety and feasibility of low-field bedside MRI in pediatric and neonatal ECMO patients. To perform imaging assessments of an early-stage magnetic resonance imaging (MRI) system on patients using low field magnetic strength. Collect qualitative data from the image assessments to optimize device performance using a low field magnetic resonance imaging device in a simulated use environment; Collect qualitative data from the image assessments using a high field magnetic resonance imaging, computed tomography and ultrasound devices. Generate anonymized image data for post-acquisition evaluation, performance measuring and planning for subsequent study size

Condition or Disease Intervention/Treatment Phase
  • Device: Hyperfine
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Low-Field Bedside Magnetic Resonance Imaging for Detection of Acute Brain Injury in Pediatric Extracorporeal Membrane Oxygenation
Actual Study Start Date :
Aug 30, 2023
Anticipated Primary Completion Date :
Aug 30, 2024
Anticipated Study Completion Date :
Aug 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Portable MRI Arm

All subjects enrolled with be assigned to Arm 1

Device: Hyperfine
Enrolled subjects will undergo a Hyperfine MRI exam, which is a portable, low-field MRI, at various timepoints during their clinical course on ECMO

Outcome Measures

Primary Outcome Measures

  1. Examining the occurrence of adverse events and serious adverse events with portable MRI use in ECMO patients [During Intervention, and immediately after intervention.]

    Measuring the occurrence of adverse events and serious adverse events that occurring during the portable MRI procedure. Adverse events and serious adverse events include (change in mean arterial pressure by 20% increase or decreased measured by the meters of mercury as identified by catheter measurement in patient, a decrease in the ECMO flow rate by 20% measured in milliliters per min by the ECMO machine, decrease in the oxygen saturation by 10% measured by pulse oximetry, dislodgement of the ECMO cannula measured by the occurrence of hemorrhage, as identified by PI).

  2. Assessing the time needed to conduct a portable MRI with ECMO patients. [Pre intervention during patient prep, and during intervention, and immediately intervention.]

    The analyses will examine the amount of time it takes to conduct a Portable MRI with ECMO patients. The examination records the amount of time to prep and move the patient to the portable MRI and back from the portable MRI. Preparation and movement of patient will be measured using a stopwatch identifying the number of minuets passed. The amount of time it takes to conduct the portable MRI with ECMO patients will also be analyzed. The time the MRI takes will be measured using a stopwatch examining the number of minuets passed.

  3. Analyzing the number of staff required to conduct a Portable MRI with an ECMO patient. [Pre intervention, during intervention, and immediately after intervention.]

    The analysis will examine the number of staff needed to prep and use a portable MRI with patients. Number of staff needed will be record in RedCap via head count.

  4. Determine the number of critical care therapies conducted during imaging studies. [Pre intervention during patient prep, during intervention, and immediately after intervention.]

    Analyzing the number of critical therapies conducted during patient prep, during intervention, and post intervention. The study will record in RedCap the number of critical care therapies identified by study coordinator and PI by counting the number of therapies. Critical care therapies include (EEG, mechanical ventilation, continuous renal replacement therapy, continuous IV infusions, temporary pacing wires).

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

  • Subjects admitted to the Pediatric Intensive Care Unit, Cardiac Intensive Care Unit, or the Neonatal Intensive Care Unit at Children's Mercy Kansas City

  • Ages 0-17 years

  • Undergoing venovenous or venoarterial ECMO Exclusion Criteria

  • Pregnancy

  • Active implants such as:

  • Pacemaker

  • Implanted defibrillator

  • Implanted insulin pump

  • Deep brain stimulator

  • Vagus nerve stimulator

  • Cochlear implant

  • Programmable shunt

  • MRI incompatible surgical hardware (e.g., staples, screws, etc.)

  • Metal-containing tattoos or permanent make-up on head or neck

  • Suspected metal in eye, e.g.,

  • Former or current welders, metal workers, or individuals with a metal injury

  • Metal shrapnel

  • Passive implants are considered MRI conditional

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's Mercy Kansas City Kansas City Missouri United States 64108

Sponsors and Collaborators

  • Children's Mercy Hospital Kansas City

Investigators

  • Principal Investigator: Jessica Wallisch, MD, Children's Mercy Kansas City

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jessica Wallisch, Pediatric Intensivist, Children's Mercy Hospital Kansas City
ClinicalTrials.gov Identifier:
NCT06074406
Other Study ID Numbers:
  • STUDY00002824
First Posted:
Oct 10, 2023
Last Update Posted:
Oct 10, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 10, 2023